You are here

  • Home
  • Archive
  • Volume 82, Issue 6
  • Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries

Article info

Article menu
Psoriatic arthritis
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries
Free

Authors

  • Bente Glintborg DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopedics, University Hospital of Copenhagen, Rigshospitalet, Copenhagen University Hospital Glostrup, Glostrup, Denmark Faculty of Health and Medical Sciences, University of Copenhagen, Kobenhavn, Denmark PubMed articlesGoogle scholar articles
  • Daniela Di Giuseppe Department of Medicine, Karolinska Universitetssjukhuset i Solna, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Johan Karlsson Wallman Department of Clinical Sciences Lund, Skåne University Hospital Lund, Lund University, Lund, Sweden Department of Rheumatology, Skåne University Hospital Lund, Lund University, Lund, Sweden PubMed articlesGoogle scholar articles
  • Dan C Nordström FOB-FIN and University of Helsinki, Helsinki University Central Hospital, Helsinki, Finland PubMed articlesGoogle scholar articles
  • Bjorn Gudbjornsson Centre for Rheumatology Research (ICEBIO), Landspitali University Hospital, Reykjavik, Iceland Faculty of Medicine, University of Iceland, Reykjavik, Iceland PubMed articlesGoogle scholar articles
  • Merete Lund Hetland DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopedics, University Hospital of Copenhagen, Rigshospitalet, Copenhagen University Hospital Glostrup, Glostrup, Denmark Faculty of Health and Medical Sciences, University of Copenhagen, Kobenhavn, Denmark PubMed articlesGoogle scholar articles
  • Johan Askling Clinical Epidemiology Division, Department of Medicine, Karolinska Universitetssjukhuset, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Gerdur Grondal Faculty of Medicine, University of Iceland, Reykjavik, Iceland Centre for Rheumatology Research, Landspitali University Hospital, Reykjavik, Iceland PubMed articlesGoogle scholar articles
  • Tuulikki Sokka Jyväskylä Central Hospital (KSSHP), Jyväskylä, Finland UEF, Faculty of Health Sciences, Kuopio, Finland PubMed articlesGoogle scholar articles
  • Sella A Provan Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway PubMed articlesGoogle scholar articles
  • Brigitte Michelsen Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway Research Unit, Hospital of Southern Norway Trust, Sorlandet Hospital Kristiansand, Kristiansand, Norway PubMed articlesGoogle scholar articles
  • Eirik Klami Kristianslund Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway PubMed articlesGoogle scholar articles
  • Lene Dreyer Department of Rheumatology, Center of Rheumatic Research Aalborg (CERRA), Aalborg University Hospital, Aalborg, Denmark Department of Clinical Medicine, Aalborg Universitet, Aalborg, Denmark PubMed articlesGoogle scholar articles
  • Thorvardur Jon Love Faculty of Medicine, University of Iceland and Department of Research, Landspitali haskolasjukrahus, Reykjavik, Iceland PubMed articlesGoogle scholar articles
  • Ulf Lindström Department of Rheumatology and Inflammation Research, University of Gothenburg Faculty of Health Sciences, Goteborg, Sweden PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Bente Glintborg, DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopedics, University Hospital of Copenhagen, Rigshospitalet, Copenhagen University Hospital Glostrup, Glostrup, Denmark; glintborg{at}dadlnet.dk
View Full Text

Citation

Glintborg B, Di Giuseppe D, Wallman JK, et al
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries
Annals of the Rheumatic Diseases 2023;82:820-828.

Publication history

  • First published February 22, 2023.
Online issue publication 
May 11, 2023

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.